Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Cycle. 2012 Jun 1;11(11):2137-45. doi: 10.4161/cc.20598. Epub 2012 Jun 1.

MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

Author information

1
Institute of Molecular and Chemical Biology, East China Normal University, Shanghai, China.

Abstract

MiR-145 is known as a tumor suppressor in numerous human cancers. However, its role in tumor angiogenesis remains poorly defined. In this study, we found that miR-145 was significantly downregulated in breast cancer tissues by using 106 cases of normal and cancer tissues as well as in breast cancer cells. MiR-145 exhibited inhibitory role in tumor angiogenesis, cell growth and invasion and tumor growth through the post-transcriptional regulation of the novel targets N-RAS and VEGF-A. In addition, we provide evidence that the expression levels of miR-145 correlate inversely with malignancy stages of breast tumors, although there is no association between miR-145 levels and hormone receptor levels in breast cancer. Taken together, these results demonstrate that miR-145 plays important inhibitory role in breast cancer malignancy by targeting N-RAS and VEGF-A, which may be potential therapeutic and diagnostic targets.

PMID:
22592534
PMCID:
PMC3368865
DOI:
10.4161/cc.20598
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center